Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial-Reference-Cited by-同舟云学术

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial

Published:2022-07 Issue: Volume:293 Page:115210
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Xiao Huan-Ming,Shi Mei-Jie^ORCID,Jiang Jun-Min,Cai Gao-Shu,Xie Yu-Bao,Tian Guang-Jun,Xue Jing-Dong,Mao De-Wen,Li Qin,Yang Hong-Zhi,Guo Hui,Lei Chun-Liang,Lu Wei,Chen Liang,Liu Hua-Bao,Wang Jing,Gao Yue-Qiu,Chen Jie-Zhen,Wu Shu-Duo,Chen Hui-Jun,Zhao Peng-Tao,Zhang Chao-Zhen,Ou-Yang Wen-Wei,Wen Ze-Huai,Chi Xiao-Ling^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference28 articles.

1. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B;Alam;Liver Int.,2011

2. The guideline of prevention and treatment for chronic hepatitis B (2010 version);association;Zhonghua Liuxingbingxue Zazhi,2011

3. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study;Boyd;J. Int. AIDS Soc.,2017

4. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings;Brook;Int. J. STD AIDS,2018

5. Progression of initially mild hepatic fibrosis in Chronic hepatitis B patients: a prospective repeat liver biopsy study;Chi;Hepatology,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The possible pathogenesis of liver fibrosis: therapeutic potential of natural polyphenols;Pharmacological Reports;2024-08-20

2. Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine;Frontiers in Pharmacology;2024-07-16

3. Chinese guidelines on the management of ascites in cirrhosis;Hepatology International;2024-07-09

4. Mairin from Huangqi Decoction Mitigates Liver Cirrhosis through Suppression of Pro-inflammatory Signaling Pathways: A Network Pharmacology and Experimental Study;The Natural Products Journal;2024-07

5. Hepatitis B: Model Systems and Therapeutic Approaches;Journal of Immunology Research;2024-05-07